Syngene International has extended its strategic collaboration with Bristol Myers [...]

Veristat, a global clinical research organization (CRO) and consultancy specializing [...]

Bicara Therapeutics has selected 1500 mg of ficerafusp alfa as [...]

Cellares has secured FDA clearance of an IND amendment allowing [...]

Breast cancer remained the world’s most studied disease for the [...]

Trialbee has secured a majority growth investment from Varsity Healthcare [...]

With the lords a-leaping, the industry is set to spring [...]

As part of Discover Pharma’s 12 days of Christmas series, [...]

As our Christmas countdown continues, we move from reflections on [...]

In 2025, patient-centricity, just like the four calling birds soared [...]